Among those currently scheduled to release results next week:
18-Nov | |
---|---|
Big Yellow Group | Half Year Results |
Melrose* | Q3 Trading Statement |
Sirius Real Estate | Half Year Results |
19-Nov | |
---|---|
Diploma | Full Year Results |
Imperial Brands* | Full Year Results |
Informa | Trading Statement |
Petershill Partners | Q3 Trading Statement |
20-Nov | |
---|---|
British Land* | Half Year Results |
Coats Group | Trading Statement |
HICL Infrastructure | Half Year Results |
Molten Ventures | Half Year Results |
Ninety One | Half Year Results |
Rotork | Q3 Trading Statement |
Sage Group | Full Year Results |
Severn Trent | Half Year Results |
Softcat | Q1 Trading Statement |
TwentyFour Income Fund | Half Year Results |
21-Nov | |
---|---|
Breedon | Q3 Trading Statement |
Britvic | Full Year Results |
Close Brothers | Q1 Trading Statement |
Grainger | Full Year Results |
Halma* | Half Year Results |
International Distribution Services* | Half Year Results |
Investec | Half Year Results |
Ithaca Energy | Q3 Results |
JD Sports* | Q3 Trading Statement |
JLEN Environmental Assets Group | Half Year Results |
Mitie Group | Half Year Results |
NextEnergy Solar Fund | Half Year Results |
NVIDIA* | Q3 Results |
Pershing Square | Q3 Results |
XPS Pensions Group | Half Year Results |
22-Nov |
---|
No FTSE 350 Reporters |
If you find our next week's stock market outlook helpful, sign up to receive in-depth share research and investment insights every Friday.
JD Sports hoping to kick on in the second half
JD Sports had a shaky start to the year, but things have since picked up, with both sales and profits moving higher over the first half. It was pleasing to see Europe, North America and Asia Pacific markets all posting double-digit sales growth. But the UK market remains challenging and volatile, and full-year profit guidance got a small downgrade as a result.
Recent retail sector data points have pointed to increased discounting at shops to help keep the tills ringing. JD’s trying to offset this by tightening its belt and streamlining operations. We’re hoping that means there won’t be further downgrades to the full-year outlook in next week's results. We’re also keen to hear how the integration of US-based Hibbett is progressing. The deal has substantially increased the group’s footprint in the US, but there’s a lot of work to do to make sure a deal of this size pulls in the expected benefits.
NVIDIA’s scalability in the spotlight at Q3 results
Nvidia’s guidance suggests that next week’s third-quarter results will deliver revenue growth of around 80% to $32.5bn. Markets forecasts expect that number to be a little higher. If NVIDIA continues its strong run of beating expectations, things could be better still but there are no guarantees. There’s likely to be more emphasis however on the outlook for the final three months of the year, where consensus is currently looking for revenue of $36.6bn.
Any steer as to how well the recently launched ultra-fast Blackwell chip is selling will also be closely scrutinised. There’s no shortage of demand as the likes of Meta, Microsoft, Google, Amazon look to gain an edge in the AI race. But there remain some unanswered questions about NVIDIA’s supply chain’s ability to keep pace.
Halma expects to keep things ticking along
Halma’s expected to keep things ticking over in next week’s half-year results with organic revenue growth, underlying operating margin expansion, and strong cash generation all on show. We’ve already had some trading details back at the end of September and performance isn’t shooting the lights out. But that’s kind of what Halma does well - consistent delivery in the face of varied economic climates.
We’ll have our eyes open for any detail on the Healthcare businesses where budget constraints are keeping a lid on customer orders. Aside from that, it’s the usual acquisition pipeline commentary that’s worth watching for, given the strategy relies as much on acquisitions as it does organic growth.
Unless otherwise stated estimates are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Past performance is not a guide to the future. Investments rise and fall in value so investors could make a loss.
This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.